Our data suggest that the gain in function or upregulation of the decoy receptors, in particular DcR2, may be important in the acquired loss of sensitivity to Apo2L/TRAIL in the osteosarcoma cell line BTK-143. The gene discussed is TNFSF10; the disease is osteosarcoma.